Market participants are focused on obtaining regulatory clearance for drugs, which is projected to fuel the growth of the global avascular necrosis market during the forecast period. Throughout the projected period, the worldwide avascular necrosis market is predicted to rise due to an increase in the number of collaborations formed by major companies. Throughout the projected period, the availability of alternative treatments is likely to impede the growth of the global avascular necrosis market. The rising number of product releases is projected to propel the global avascular necrosis market forward. A growing number of inorganic development tactics, such as distribution by important market participants, are predicted to fuel worldwide expansion.
According to Coherent Market Insights, the global Avascular Necrosis Market is estimated to be valued at US$ 605.0 Mn in 2021 and is expected to exhibit a CAGR of 6.0% over the forecast period (2021-2028).
Key Leaders in the Avascular Necrosis Industry:
1. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
2. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. In August 2021, Dr. Reddy’s Laboratories Ltd., a pharmaceutical company announced the re-launch of over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
3. Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offering services, including CRAMS and contract manufacturing for APIs. Founded in 2017, headquartered in Tamil Nadu, India.
4. Bayer AG
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. Founded in 1863, headquartered in Germany.
5. Alkem labs
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas. Founded in 1973, headquartered in Mumbai, India.
6. Novartis AG
The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. In January 2020, Novartis AG announced that it had completed acquisition of The Medicines Company, a pharmaceutical company. The Medicines Company has submitted the New Drug Application (NDA) for inclisiran, a low-density lipoprotein cholesterol (LDL-C) drug to the U.S. FDA in December 2019. Thus, this acquisition will expand the product portfolio of Novartis AG. In December 2020, Novartis AG, a pharmaceutical company, announced that the European Commission (EC) had approved Leqvio (inclisiran) for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. Leqvio is a first-in-class small interfering RNA (siRNA) providing effective and sustained LDL-C reduction for patients with atherosclerotic cardiovascular disease (ASCVD).
7. GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV. Founded in 2000, headquartered in England, U.K.
8. Pfizer, Inc.
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide
*Definition- Avascular necrosis, also known as osteonecrosis, is the destruction of bone tissue as a result of a lack of blood flow.
